| Stem definition | Drug id | CAS RN |
|---|---|---|
| 2742 | 146-54-3 |
| Dose | Unit | Route |
|---|---|---|
| 0.10 | g | O |
| 0.10 | g | P |
None
| Date | Agency | Company | Orphan |
|---|---|---|---|
| Sept. 16, 1957 | FDA |
None
None
None
None
| Source | Code | Description |
|---|---|---|
| ATC | N05AA05 | NERVOUS SYSTEM PSYCHOLEPTICS ANTIPSYCHOTICS Phenothiazines with aliphatic side-chain |
| CHEBI has role | CHEBI:48561 | dopaminergic antagonists |
| CHEBI has role | CHEBI:50919 | antiemetico |
| CHEBI has role | CHEBI:65190 | typical antipsychotic drugs |
| CHEBI has role | CHEBI:149553 | anticoronaviral drug |
| MeSH PA | D000932 | Antiemetics |
| MeSH PA | D014150 | Antipsychotic Agents |
| MeSH PA | D002491 | Central Nervous System Agents |
| MeSH PA | D002492 | Central Nervous System Depressants |
| MeSH PA | D015259 | Dopamine Agents |
| MeSH PA | D018492 | Dopamine Antagonists |
| MeSH PA | D005765 | Gastrointestinal Agents |
| MeSH PA | D018377 | Neurotransmitter Agents |
| MeSH PA | D018373 | Peripheral Nervous System Agents |
| MeSH PA | D011619 | Psychotropic Drugs |
| MeSH PA | D014149 | Tranquilizing Agents |
| Disease | Relation | SNOMED_ID | DOID |
|---|---|---|---|
| Nausea and vomiting | indication | 16932000 | |
| Psychotic disorder | indication | 69322001 | |
| Vomiting | indication | 422400008 | |
| Nausea | indication | 422587007 | |
| Alcoholism | contraindication | 7200002 | |
| Organophosphate poisoning | contraindication | 8260003 | |
| Weight gain finding | contraindication | 8943002 | |
| Neuroleptic malignant syndrome | contraindication | 15244003 | DOID:14464 |
| Senile dementia | contraindication | 15662003 | |
| Chronic disease of respiratory system | contraindication | 17097001 | |
| Myocardial infarction | contraindication | 22298006 | DOID:5844 |
| Glaucoma | contraindication | 23986001 | DOID:1686 |
| Orthostatic hypotension | contraindication | 28651003 | |
| Torsades de pointes | contraindication | 31722008 | |
| Parkinsonism | contraindication | 32798002 | |
| Conduction disorder of the heart | contraindication | 44808001 | |
| Chronic heart failure | contraindication | 48447003 | |
| Bradycardia | contraindication | 48867003 | |
| Extrapyramidal disease | contraindication | 76349003 | |
| Hyperglycemia | contraindication | 80394007 | DOID:4195 |
| Epilepsy | contraindication | 84757009 | DOID:1826 |
| Leukopenia | contraindication | 84828003 | DOID:615 |
| Stupor | contraindication | 89458003 | |
| Tardive dyskinesia | contraindication | 102449007 | |
| Prolonged QT interval | contraindication | 111975006 | |
| Acute disease of cardiovascular system | contraindication | 128487001 | |
| Angina pectoris | contraindication | 194828000 | |
| Disease of liver | contraindication | 235856003 | DOID:409 |
| Metabolic syndrome X | contraindication | 237602007 | DOID:14221 |
| Hyperprolactinemia | contraindication | 237662005 | DOID:12700 |
| Benign prostatic hyperplasia | contraindication | 266569009 | |
| Retention of urine | contraindication | 267064002 | |
| Anemia | contraindication | 271737000 | DOID:2355 |
| Thrombocytopenic disorder | contraindication | 302215000 | DOID:1588 |
| Neutropenic disorder | contraindication | 303011007 | DOID:1227 |
| Coma | contraindication | 371632003 | |
| At risk for aspiration | contraindication | 371736008 | |
| Visual impairment | contraindication | 397540003 | |
| Breastfeeding (mother) | contraindication | 413712001 | |
| Myocardial ischemia | contraindication | 414795007 | DOID:3393 |
| Obesity | contraindication | 414916001 | DOID:9970 |
| Congenital long QT syndrome | contraindication | 442917000 | |
| Carcinoma of female breast | contraindication | 447782002 |
| Species | Use | Relation |
|---|---|---|
| Dogs | Anxiety | Indication |
| Dogs | Control psychomotor overactivity | Indication |
| Dogs | Pain and pruritus | Indication |
| Cats | Anxiety | Indication |
| Cats | Control psychomotor overactivity | Indication |
| Cats | Pain and pruritus | Indication |
| Horses | Anxiety | Indication |
| Horses | Control psychomotor overactivity | Indication |
| Horses | Pain and pruritus | Indication |
| Product | Applicant | Ingredients |
|---|---|---|
| Vetame Injectable, Vetame Tablets | Zoetis Inc. | 1 |
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 9.04 | Basic |
| pKa2 | 2.72 | Basic |
None
None
| Target | Class | Pharos | UniProt | Action | Type | Activity value (-log[M]) | Mechanism action | Bioact source | MoA source |
|---|---|---|---|---|---|---|---|---|---|
| D(2) dopamine receptor | GPCR | ANTAGONIST | Ki | 8.55 | PDSP | CHEMBL | |||
| Multidrug resistance protein 1 | Transporter | Ki | 4.80 | CHEMBL | |||||
| 5-hydroxytryptamine receptor 2A | GPCR | Ki | 8.40 | PDSP | |||||
| Trypanothione reductase | Enzyme | Ki | 4.52 | CHEMBL | |||||
| Cholinesterase | Enzyme | IC50 | 5.13 | CHEMBL | |||||
| Pleiotropic ABC efflux transporter of multiple drugs | Transporter | IC50 | 5.31 | CHEMBL |
| ID | Source |
|---|---|
| 4019958 | VUID |
| N0000148043 | NUI |
| D00390 | KEGG_DRUG |
| 1098-60-8 | SECONDARY_CAS_RN |
| 4017744 | VANDF |
| 4019958 | VANDF |
| C0040989 | UMLSCUI |
| CHEBI:9711 | CHEBI |
| CHEMBL570 | ChEMBL_ID |
| DB00508 | DRUGBANK_ID |
| D014273 | MESH_DESCRIPTOR_UI |
| 5568 | PUBCHEM_CID |
| 4330 | IUPHAR_LIGAND_ID |
| 725 | INN_ID |
| RO16TQF95Y | UNII |
| 10805 | RXNORM |
| 5626 | MMSL |
| d03152 | MMSL |
| 001472 | NDDF |
| 004589 | NDDF |
| 30329006 | SNOMEDCT_US |
| 398816002 | SNOMEDCT_US |
| 6992002 | SNOMEDCT_US |
| CHEMBL1201102 | ChEMBL_ID |
None